Back

Five year all-cause mortality and dual anti-platelet therapy after transcatheter aortic valve implantation

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 6 - Valvular disease Surgery and intervention in valve disease ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Emmanouil Vavouranakis

National & Kapodistrian University of Athens Medical School, Athens (Greece)

26 More presentations in this session

Presentation thumbnail
The obesity paradox in patients undergoing transcatheter aortic valve implantation
Mr R. Hoellriegel (Dresden, DE)
Abstract
Presentation thumbnail
Lower trans-aortic flow rate is associated with increased cardiovascular and all-cause mortality in aortic valve stenosis
Doctor S. Saeed (Bergen, NO)
Abstract
Presentation thumbnail
High sensitivity troponin T plasma levels predict postoperative survival in patients with severe aortic stenosis undergoing valve implantation
Doctor F. Barbieri (Berlin, DE)
Abstract Slides
Presentation thumbnail
Quality of life in high risk patients with severe aortic stenosis treated either with AVR or TAVI
Doctor C. Ciuca (Bologna, IT)
Abstract Slides
Presentation thumbnail
Higher left ventricular mass-stress-heart rate product is associated with increased cardiovascular morbidity and mortality in aortic valve stenosis
Professor E. Gerdts (Bergen, NO)
Abstract

Access the full session

Session thumbnail
Poster session 6 - Valvular disease

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources